A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

Summary

This is a multicenter, double blind, placebo controlled, multiple dose study to examine the safety and efficacy of MNK-1411 in male subjects 4 to 8 years of age (inclusive) with Duchenne Muscular Dystrophy (DMD).

Timeline

Start

2018-07-27

Primary completion

2020-02-25

Completion

2020-02-25

Outcome

Outcome not reported

Stopped (Enrollment): “Slow enrollment”

Drugs

Indications